Peter Stimpson
General Practice · Loudon, TNNPI 1467463828
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,009 and has fallen 72.6% since, to $277 in 2022. Among general practice clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$300
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$260
- Lilly USA, LLC$208
- Pfizer$208
- Johnson & Johnson$140
- Esperion Therapeutics, Inc.$138
- plus $1K from 22 others
Across 2 payments — averaging $200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$400
What the payments were for
- Speaking & faculty fees$1857%
- Food & beverage$2,29193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 21 | $300 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $260 |
| Lilly USA, LLC | 12 | $208 |
| Pfizer | 13 | $208 |
| Johnson & Johnson(2 entities) | 4 | $140 |
| Esperion Therapeutics, Inc. | 5 | $138 |
| Sanofi-aventis U.S. LLC | 6 | $121 |
| Boehringer Ingelheim | 7 | $115 |
| Sanofi | 1 | $110 |
| GSK | 7 | $107 |
| Novo Nordisk | 5 | $94 |
| Bayer | 2 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $75 |
| Novartis | 2 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $63 |
| AbbVie(2 entities) | 4 | $61 |
| AstraZeneca | 4 | $52 |
| Indivior Inc. | 3 | $47 |
| Merck | 3 | $46 |
| Orexo US, Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,476 in reported general payments places this provider in the 90th percentile of 1,632 general practice providers in Tennessee.
Other general practice in Loudon
- Nathan GlennWinchester$874K
- Charles HooperChattanooga$158K
- Randall MontgomeryKingsport$92K
- Toluwalashe OnamusiNashville$80K
- Jonathon RogersGreeneville$60K
- Phillip KempBrentwood$50K
- Charles HooperChattanooga$38K
- Phillip TischbeinSmyrna$30K
- Joseph HolleyKnoxville$28K
- David ParkerKnoxville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.